Ticker Details
Gyre Therapeutics, Inc.
IPO Date:	August 21, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$797.64M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.29 | 3.77%
Avg Daily Range (30 D):	$0.16 | 1.99%
Avg Daily Range (90 D):	$0.18 | 2.28%

Institutional Daily Volume
Avg Daily Volume:	.77M
Avg Daily Volume (30 D):	.05M
Avg Daily Volume (90 D):	.06M

Trade Size
Avg Trade Size (Sh.):	448
Avg Trade Size (Sh.) (30 D):	70
Avg Trade Size (Sh.) (90 D):	67

Institutional Trades
Total Institutional Trades:	122
Avg Institutional Trade:	$1.59M
Avg Institutional Trade (30 D):	$1.52M
Avg Institutional Trade (90 D):	$1.52M
Avg Institutional Trade Volume:	.46M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.79M
Avg Closing Trade (30 D):	$1.52M
Avg Closing Trade (90 D):	$1.52M
Avg Closing Volume:	567.53K

News

Nov 7, 2025 @ 11:00 AM Gyre Therapeutics Reports Third Quarter 2025 and Y... Source: Gyre Therapeutics

Oct 14, 2025 @ 11:00 AM Gyre Therapeutics to Present Results from Positive... Source: Prof. Lungen Lu, M.D.

Aug 22, 2025 @ 11:00 AM Gyre Therapeutics Announces the Appointment of Dan... Source: Gyre Therapeutics

Jun 10, 2025 @ 11:00 AM Gyre Therapeutics Announces First Dosing in Phase ... Source: N/A

May 23, 2025 @ 12:57 AM Gyre Therapeutics Announces Pricing of $20.0 Milli... Source: N/A

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$.04	$	$.03
Diluted EPS	$.03	$	$
Revenue	$30.56M	$26.77M	$22.06M
Gross Profit	$28.94M	$25.62M	$21.16M
Net Income / Loss	$8.26M	$1.58M	$3.73M
Operating Income / Loss	$6.93M	$2.17M	$2.27M
Cost of Revenue	$1.63M	$1.15M	$.89M
Net Cash Flow	$3.79M	$21.4M	$3.18M
PE Ratio	280.00

Splits
Jan 13, 2023	2:1
Feb 13, 2017	1:15
Aug 21, 2015	1:7